Lemon and CBD Cake

Feeling a bit tired around nap time? Go into “tea time” mode with our twist on a famous lemon cake recipe. Nothing like it to revive the taste buds, and endocannabinoids. Especially, if you accompany your cake with a CBD tea.

Ingredients

(For 6 people)

– 200g sugar
– 120g melted butter
– 150g of flour
– 3 eggs
– 3 lemons

– Zest of one lemon
– 1 teaspoon of baking powder
– Powdered sugar
– 10 drops of 4% cbd

Preparation

Prepare the cake tin by putting soft butter on the sides and putting baking paper.

Melt the butter in pieces in a saucepan. Pour it in a bowl and add the sugar, the CBD, the zest of a lemon, then mix. Add the eggs one by one, mixing each time, then the flour and the yeast while whisking the mixture.

Tip: you can replace the melted butter with a hazelnut butter (browned over low heat) which will give a better taste.

Cut the lemons in half and squeeze them to obtain the juice. You must incorporate 80g of lemon juice in the mixture obtained. If there is any extra juice, make a lemon squeeze with it!

Pour the batter into the cake pan and bake for 45 minutes in a preheated oven at 165°. Check the cooking by placing the blade of a knife in the heart of the cake. When it comes out clean (dry) your cake is cooked. If not, extend the cooking time by 5 minutes.

Turn the cake out onto a rack and wrap it in plastic wrap so that it stays soft as it cools. Remove the plastic wrap when the cake is cooled.

Variation

From an aesthetic point of view, and also for greed, you can make a glaze for your cake. To do this, mix powdered sugar with the juice of half a lemon, the equivalent of about 30 grams of lemon juice. You must obtain a white icing, not too hard, but not too liquid either. If necessary, adjust your dosage.

When your cake is cooled, place it on a rack, itself placed on a dish (to recover the glaze surplus) and cover the cake with your glaze. But as today we eat first with our eyes and we make everyone enjoy it, don’t forget the little picture!

NFL Teams up With Canadian Researchers for Groundbreaking CBD Study

The collaboration between the NFL and Canadian researchers for a groundbreaking CBD study has sparked immense interest and anticipation within the sports community.

As the NFL continues to invest in CBD research, this study aims to explore the potential benefits of CBD for pain management and neuroprotection, particularly in relation to concussions.

With the objective of identifying the optimal dosage and investigating its anti-inflammatory and neuroprotective effects, this study holds significant implications for both athletes and the evolving landscape of drug testing policies in sports.

The partnership between the NFL and the University of Regina represents a significant step towards advancing our understanding of CBD's potential and its potential impact on pain management and neuroprotection.

Key Takeaways

• The NFL is partnering with Canadian researchers to conduct a clinical trial on the safety and efficacy of CBD for pain management and neuroprotection from concussions.
• The study will involve 35 participants receiving either a placebo or a CBD-rich cannabis extract, with the aim of identifying the optimal dose of CBD for daily use.
• The research will also investigate the anti-inflammatory and neuroprotective effects of CBD formulations, as well as their safety and tolerance during periods of intensive exercise.
• The NFL has committed significant funding to CBD research, including $1 million in 2022 and support for independent studies at the University of California San Diego. The league and players union have shown a strong interest in CBD research, leading to changes in drug testing policies in sports.

NFL's Groundbreaking CBD Study

The NFL is embarking on a groundbreaking CBD study in collaboration with Canadian researchers from the University of Regina. This study aims to explore CBD's potential benefits for athletes, specifically its impact on concussion recovery.

The phase 1 trial will involve 35 participants who will receive either a placebo or a CBD-rich cannabis extract. The study's objectives include identifying the optimal dose of CBD for daily use, investigating its anti-inflammatory and neuroprotective effects, and determining its safety and tolerance during periods of intensive exercise.

The NFL has committed significant funding to CBD research in recent years, with a particular focus on pain management and neuroprotection. This partnership with Canadian researchers demonstrates the league's commitment to exploring alternative therapies for player health and well-being.

Study Design and Objectives

The study aims to investigate the optimal dose and effects of CBD for daily use in pain management and neuroprotection, with a particular focus on safety and tolerance during periods of intensive exercise.

The objectives of the study include:

1. Identifying the optimal dose of CBD for athletes: The study will start with a dosage of 5 milligrams per kilogram of body weight and gradually increase to determine the most effective dosage for pain management and neuroprotection.
2. Assessing the anti-inflammatory and neuroprotective effects of CBD: The researchers will investigate the potential benefits of CBD in reducing inflammation and protecting the brain from concussions and other traumatic injuries.
3. Determining the safety and tolerance of CBD during intensive exercise: The study will examine how CBD affects athletes during periods of intense physical activity, ensuring that it does not impair performance or pose any health risks.

These objectives have important implications for sports medicine, as they aim to provide insights into the potential benefits of CBD for athletes and inform safe and effective use in pain management and neuroprotection.

NFL's Funding and Support for CBD Research

Continuing their commitment to CBD research, the NFL has provided significant funding and support for studies exploring the potential benefits of CBD in pain management and neuroprotection. The NFL has committed hundreds of thousands of dollars to CBD research in recent years, with a specific focus on implications for player safety.

In 2022, the NFL committed $1 million to cannabis trials, including funding for a separate study at the University of California San Diego. The league, along with the players union, is jointly awarding funding for independent research on CBD. This notable investment by the NFL demonstrates their strong interest in understanding the impact of CBD on player health and safety.

Additionally, the NFL's support for CBD research is likely to have a significant impact on the CBD industry, as their findings and recommendations may shape regulations and policies surrounding CBD use in professional sports.

Changing Drug Testing Policies in Sports

Changing drug testing policies in sports have been implemented across various leagues and organizations, reflecting a growing recognition of the evolving attitudes towards substances such as marijuana and CBD. These policy changes have had a significant impact on the sports world, with athletes and organizations embracing the use of CBD and advocating for its acceptance.

Some of the notable changes include:

1. Proposal impact: The proposal to remove marijuana from NCAA drug screenings for championships has the potential to greatly impact college athletes, allowing them to use CBD without fear of repercussions.
2. Athlete acceptance: The UFC's decision to formally remove marijuana from its banned substances list for athletes demonstrates the growing acceptance of CBD among fighters, who often use it for pain management and recovery.
3. NBA agreement: The NBA and its players union signed an agreement removing marijuana from the league's banned substances list, showing a willingness to adapt to changing attitudes towards CBD and marijuana.

These changes reflect a shifting landscape in sports, as athletes and organizations recognize the potential benefits of CBD and advocate for its use in a responsible and regulated manner.

CBD Partnerships in Other Sports Leagues

As the acceptance of CBD continues to grow in the world of sports, various leagues and organizations have formed partnerships with CBD companies to explore its potential benefits.

In 2022, Major League Baseball (MLB) announced a league-wide partnership with a popular CBD brand. This partnership aims to promote the use of CBD products among MLB players for pain management and recovery.

Additionally, there have been calls for reform in NCAA drug screenings, including the proposal to remove marijuana from the list of banned substances. This reform would allow collegiate athletes to use CBD products without fear of penalties or disqualification.

These partnerships and proposed reforms highlight the increasing recognition of CBD's potential in improving athlete well-being and performance across different sports leagues.

Implications for Pain Management and Neuroprotection

The study on CBD's implications for pain management and neuroprotection in collaboration with the NFL and Canadian researchers aims to determine the optimal dose of CBD for daily use and investigate its anti-inflammatory and neuroprotective effects. This groundbreaking research holds significant potential for various applications, including concussion recovery and chronic pain relief.

Here are three key implications of this study:

1. Concussion Recovery: CBD's potential impact on concussion recovery is of great interest, as it may help mitigate the symptoms associated with brain injuries. By exploring CBD's neuroprotective effects, researchers hope to uncover its ability to aid in the healing process and promote brain health.
2. Chronic Pain Relief: CBD's effectiveness for chronic pain relief is another crucial focus of this study. The anti-inflammatory properties of CBD may offer a natural and alternative solution for individuals suffering from chronic pain conditions, providing much-needed relief without the potential side effects of traditional pain medications.
3. Optimal Dose Determination: The study also seeks to identify the optimal dose of CBD for daily use. By gradually increasing the dosage and monitoring its effects on pain management and neuroprotection, researchers aim to establish safe and effective guidelines for CBD consumption in these contexts.

This collaborative research between the NFL and Canadian researchers has the potential to revolutionize pain management and neuroprotection strategies, offering new insights into CBD's therapeutic benefits.

Frequently Asked Questions

What Is the Specific Timeline for the Clinical Trial Involving the NFL and Canadian Researchers?

The specific timeline for the clinical trial involving the NFL and Canadian researchers has not been provided in the given information. Further details regarding the timeline are not available at this time.

How Will the Participants in the Study Be Selected and Recruited?

Participants for the study will be selected through a rigorous selection process, which may include criteria such as age, gender, medical history, and willingness to comply with study protocols. Recruitment methods will involve reaching out to potential candidates through various channels, such as medical clinics, advertisements, and referrals from healthcare professionals.

Are There Any Potential Risks or Side Effects Associated With CBD Use in the Study?

Potential risks and side effects associated with CBD use in the study will be thoroughly evaluated. The study aims to determine the safety and tolerance of CBD during periods of intensive exercise, with a focus on neuroprotection and pain management.

What Other Universities or Institutions Are Involved in the Nfl's Funding for CBD Research?

The NFL's funding for CBD research involves partnerships with various universities and institutions. This includes the University of California San Diego, where a separate study is being conducted, as well as collaborations with researchers at the University of Regina in Canada.

Are There Any Plans to Expand the Study to Include a Larger Number of Participants in the Future?

Currently, there is no information available regarding the expansion of the participant pool or future plans for the groundbreaking CBD study conducted by the NFL in collaboration with Canadian researchers.

Conclusion

In a groundbreaking collaboration, the NFL has partnered with Canadian researchers to conduct a phase 1 clinical trial on CBD for pain management and neuroprotection in relation to concussions.

This study aims to identify the optimal CBD dosage for daily use, investigate its anti-inflammatory and neuroprotective effects, and determine its safety during intensive exercise.

With significant funding from the NFL, this research contributes to our understanding of CBD's potential benefits and its impact on drug testing policies in sports.

Groundbreaking Study Challenges Cannabis's Role in Reducing Opioid Use

The relationship between cannabis use and its potential to reduce opioid use has long been a topic of interest and debate. However, a groundbreaking study conducted by the University of Sydney and published in the American Journal of Psychiatry challenges previous claims and raises important questions about the role of cannabis in reducing opioid use.

This study, which followed individuals with heroin dependence over a 20-year period, suggests that there is no clear relationship between cannabis use and long-term illicit opioid use. These findings have significant implications for clinicians and policymakers who have considered cannabis as a potential solution for combating the opioid crisis.

In this discussion, we will delve into the study's findings, explore the limitations of previous research, and examine the implications for current policies surrounding cannabis use and opioid addiction.

Key Takeaways

• A study conducted by the University of Sydney found no evidence that cannabis reduces long-term illicit opioid use.
• Cannabis use did not show a clear relationship with opioid use, challenging claims that cannabis can help with opioid use disorders.
• Clinicians and policymakers should not rely on cannabis as a solution for reducing opioid use, as the lack of evidence suggests it is not effective.
• The inclusion of opioid use disorder as a qualifying condition for medical cannabis prescriptions should be reconsidered by policymakers.

Study Overview and Findings

The study conducted by the University of Sydney and published in the American Journal of Psychiatry provides a comprehensive overview of the relationship between cannabis use and long-term illicit opioid use in individuals with heroin dependence.

This groundbreaking study followed 615 people with heroin dependence over a 20-year period, making it the longest study to date on this topic.

The aim of the study was to examine the impact of cannabis on opioid use disorders.

The results of the study found no evidence to support the claim that cannabis reduces long-term illicit opioid use.

Additionally, cannabis use did not show a clear relationship with opioid use.

These findings challenge the belief that cannabis can be used as a tool for reducing opioid use disorders.

Therefore, clinicians and policymakers should not rely on cannabis as a solution for reducing opioid use, and the growing access to cannabis products should not be seen as a solution to the opioid crisis.

The Opioid Crisis and Its Burden

The opioid crisis continues to impose a significant burden on societies, causing more death and disability than any other illicit drug. Opioid dependence can lead to various health problems, making it crucial to address this crisis with holistic approaches. A comprehensive treatment approach should include physical, psychological, and pharmacotherapy therapies. To provide a visual representation of the burden of the opioid crisis, the following table illustrates the number of deaths and disability-adjusted life years (DALYs) caused by opioids in Australia and North America:

These statistics highlight the severity of the crisis and emphasize the need for effective interventions. While cannabis has been suggested as a potential solution, the recent groundbreaking study challenges its role in reducing opioid use. Policymakers and clinicians should not rely on cannabis as a means to reduce opioid use and instead focus on evidence-based approaches to tackle this crisis.

Previous Studies and Limitations

Existing research on the relationship between cannabis and opioid use has been limited in duration, hindering our understanding of the potential effects of cannabis on opioid use. Previous studies have primarily focused on a single follow-up point, providing only a snapshot of the relationship between cannabis and opioids. This lack of long-term studies limits our ability to fully comprehend the long-term effects and potential benefits of cannabis in reducing opioid use.

To address this limitation, the groundbreaking study conducted by the University of Sydney followed 615 individuals with heroin dependence over a 20-year period, making it the longest study to date on this topic. This extended follow-up period allowed researchers to gain valuable insights into the relationship between cannabis and opioid use, challenging previous claims that cannabis can help with opioid use disorders.

These findings emphasize the need for longer studies to further investigate the potential effects of cannabis on opioid use and caution against relying on cannabis as a solution for reducing opioid use.

Misconceptions and Policy Implications

Given the limitations of previous studies on the relationship between cannabis and opioid use, it is imperative to address the misconceptions surrounding this topic and consider the policy implications that arise from these findings.

Initial low-quality research suggested that cannabis could reduce opioid use, leading to the inclusion of opioid use disorder as a qualifying condition for medical cannabis prescriptions. However, repeated studies have found a reversal of this association and increased opioid-related harm.

The recent groundbreaking study conducted by the University of Sydney challenges the idea that cannabis can help with opioid use disorders. These findings support the need to reevaluate medical cannabis prescriptions and reconsider the inclusion of opioid use disorder as a qualifying condition.

Policymakers should take these results into account when shaping public health policies related to opioid use.

Reconsidering Cannabis's Role in Opioid Use Disorder

Reevaluating the potential impact of cannabis on opioid use disorder requires a comprehensive and evidence-based approach to inform policy decisions. As the recent groundbreaking study challenges the notion that cannabis can reduce opioid use, it is crucial to consider alternative approaches to opioid addiction.

Here are four key points to consider:

1. Holistic Treatment: Opioid use disorders are complex and require holistic approaches. Treatment options should include a combination of physical, psychological, and pharmacotherapy therapies.
2. Long-term Studies: Previous studies on the relationship between cannabis and opioids have been limited in duration. Longer-term studies, like the 20-year follow-up study conducted by the University of Sydney, are needed to further investigate the potential effects of cannabis on opioid use.
3. Lack of Evidence: The study found no evidence that cannabis reduces long-term illicit opioid use. This lack of evidence suggests that clinicians and policymakers should not rely on cannabis as a solution for reducing opioid use.
4. Policy Implications: Misconceptions about the potential role of cannabis in reducing opioid use disorder have led to the inclusion of it as a qualifying condition for medical cannabis prescriptions. Policymakers should reconsider this inclusion and base policy decisions on scientific evidence rather than assumptions.

Frequently Asked Questions

What Were the Specific Findings of the Study Regarding the Relationship Between Cannabis and Illicit Opioid Use?

The study found no evidence to support the role of cannabis in reducing illicit opioid use. The relationship between cannabis and opioid use was not clear. Clinicians and policymakers should not rely on cannabis as a solution for opioid use problems.

Did the Study Find Any Evidence to Support the Claim That Cannabis Can Help With Opioid Use Disorders?

The study found no evidence to support the claim that cannabis can help with opioid use disorders. The lack of a clear relationship between cannabis and opioid use challenges the notion that cannabis is effective in reducing opioid use disorders.

What Are the Potential Implications of the Study's Findings for Clinicians and Policymakers?

The study's findings have important implications for clinicians and policymakers. The lack of evidence supporting cannabis's role in reducing opioid use suggests that clinicians should not rely on it as a treatment option. Policymakers should reconsider including opioid use disorder as a qualifying condition for medical cannabis prescriptions.

How Does the Burden of Opioids Compare to That of Other Illicit Drugs?

The burden of opioids surpasses that of any other illicit drug, causing more death and disability. The opioid crisis has a significant impact on countries like Australia and North America, necessitating holistic approaches that include various therapies for treatment.

What Are Some Potential Holistic Approaches to Treating Opioid Use Disorders?

Holistic approaches to treating opioid use disorders may include a combination of physical, psychological, and pharmacotherapy therapies. Alternative therapies such as acupuncture, yoga, and mindfulness-based interventions can also be considered to address the complex nature of opioid use disorders.

Conclusion

In conclusion, the recently published study challenges the notion that cannabis can reduce long-term illicit opioid use. With no clear relationship found between cannabis use and opioid use, it is essential for clinicians and policymakers to reconsider their approach to tackling the opioid crisis.

The findings highlight the need for holistic approaches that encompass physical, psychological, and pharmacotherapy therapies. As we continue to explore solutions for opioid addiction, it is crucial to base our decisions on objective, evidence-based research.

Top 6 reasons to try CBD

We see more and more people around us consuming CBD and you hesitate to try? Its “miracle product” side leaves you skeptical? We must admit that all the virtues that we lend it may seem “too good to be true”, but the potential of CBD is confirmed more and more over the years, whether in terms of consumer feedback, or with scientific research. If you are still not convinced, here are some reasons that should change your mind!

It soothes everyday ailments in a natural way

First of all, you should know that CBD is a totally legal molecule. Unlike its cousin THC, it does not induce any high or any other side effect. You do not have any risk of addiction to try CBD, because it is directly extracted from the hemp plant. Completely natural, it relieves you and will eventually prevent you from using a heavier drug treatment!

It reduces stress

Known for its relaxing effects, CBD undoubtedly helps you relax, but can also act as a mild antidepressant. So you can try CBD in times of increased stress, to help reduce your anxiety disorders: a few drops of CBD oil or a hemp tea will do the trick!

It provides a better sleep

The human body reacts to CBD because it interacts with the receptors of the endocannabinoid system, which is directly linked to the nervous and immune systems. This system also plays a role in the body’s homeostasis, which helps regulate our sleep cycles: a better regulated homeostasis cycle makes it easier to fall asleep, while enjoying a much better quality of sleep.

It relieves chronic pain

Another reason to try CBD is its proven anti-inflammatory effect. According to some studies, this product could soothe certain joint pains such as osteoarthritis, but also back pain and certain neurological ailments! Why deprive yourself of it?

It improves recovery after exercise

Contrary to popular belief, CBD is not reserved for people subject to stress or physical problems! Indeed, more and more athletes are trying it, because the use of CBD-based oils or balms allows them to recover better, by relaxing their muscles after an effort!

It takes care of your skin

Combined with hemp oil, CBD is particularly useful against skin problems. Thanks to its moisturizing, antiseptic, and anti-inflammatory properties, it helps regulate sebum production. You should therefore try it if you suffer from skin problems such as eczema, hives or psoriasis… It is even effective in relieving your sunburn!